Inactive Instrument
Eidos Therapeutics, Inc. Stock
Stocks
EIDX
US28249H1041
Biotechnology & Medical Research
| 1 day | -4.85% |
| Manager | Title | Age | Since |
|---|---|---|---|
Neil Kumar
CEO | Chief Executive Officer | 47 | 01/03/2016 |
Jonathan Fox
PSD | President | 69 | 01/10/2016 |
Uma Sinha
CTO | Chief Tech/Sci/R&D Officer | 69 | 01/06/2016 |
| Director | Title | Age | Since |
|---|---|---|---|
Jonathan A. Barr
BRD | Director/Board Member | - | 26/01/2021 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 26/01/21 | Tender | Director | 113,325 | 0.2916% | ||
| 26/01/21 | Issuer sale | Director | 25,973 | 0.0668% | ||
| 26/01/21 | Don | Chief Technology Officer | 366,525 | 0.9431% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -4.85% | -4.63% | - | - | 4.75B | |
| -0.94% | +0.31% | +40.04% | +103.25% | 69.19B | |
| -0.07% | -3.93% | +32.54% | +75.96% | 62.97B | |
| +3.25% | +2.19% | -12.09% | +388.32% | 27.27B | |
| -0.64% | -5.49% | -3.89% | -16.82% | 24.78B | |
| -0.93% | -1.29% | +25.30% | +16.70% | 25.8B | |
| -1.43% | -1.89% | +21.32% | -17.67% | 20.11B | |
| -4.27% | +2.67% | +219.02% | +362.48% | 18.47B | |
| -1.43% | -1.80% | -8.64% | +537.09% | 14.88B | |
| +1.29% | -1.09% | +51.23% | +163.26% | 14.29B | |
| Average | -1.04% | -0.31% | +40.53% | +179.18% | 30.86B | |
| Weighted average by Cap. | -0.56% | -0.76% | +36.45% | +141.11% |
Employees
-
